TransMedics Group, Inc.
- TMDX
- NASDAQ
- Medical devices
- Organ Transplant Technology
- Organ Perfusion Systems
$70.78
Today −7.50%Quote Oct 16, 2026, 08:00 PM UTC
−18.32%over the last month
Max drawdown −19.6%From 1-month high −19.6%3 months −3.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$2.45B
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$99.63
+40.8% from here
Floor
$68.76
2.9% below price
Where the price sits
13 analysts
Analyst range, low to high
$65.00$122.00
- Price $70.78
- Resistance $70.51–$71.22
- Consensus $99.63
Analysts' average target sits about 41% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TMDXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $189.9M
- Product$111.2M58.5%
- Service$78.8M41.5%
Industry
Medical devices
Employees
898
Founded
1998